A moderate elevation of circulating levels of IGF-I does not alter ErbB2 induced mammary tumorigenesis

<p>Abstract</p> <p>Background</p> <p>Epidemiological evidence suggests that moderately elevated levels of circulating insulin-like growth factor-I (IGF-I) are associated with increased risk of breast cancer in women. How circulating IGF-I may promote breast cancer incidence is unknown, however, incr...

Celý popis

Podrobná bibliografie

Hlavní autoři:	Brown Powel H, Hilsenbeck Susan G, Liao Lan, Wang Yu-Fen, Kuiatse Isere, Dearth Robert K, Xu Jianming, Lee Adrian V
Médium:	Artigo
Jazyk:	Inglês
Vydáno:	BMC 2011-08-01
Edice:	BMC Cancer
On-line přístup:	http://www.biomedcentral.com/1471-2407/11/377
Tagy:	Přidat tag Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!